Abstract:G-quadruplexes (G4s) are higher-order structures formed by guanine-rich sequences of nucleic acids, such as the telomeric 5′-TTAGGG-3′/5′-UUAGGG-3′ repeats and those in gene regulatory regions. G4s regulate various biological events, including replication, transcription, and translation. Imbalanced G4 dynamics is associated with diseases, such as cancer and neurodegenerative diseases. Telomestatin is a natural macrocyclic compound derived from <i>Streptomyces anulatus</i> 3533-SV4. It interacts with the guanine quartet via π-π stacking and potently stabilizes G4. Because G4 stabilization at the telomeric repeat inhibits the telomere-synthesizing enzyme telomerase, telomestatin was originally identified as a telomerase inhibitor. Whereas non-toxic doses of telomestatin induce gradual shortening of telomeres and eventual crisis in human cancer cells, higher doses trigger prompt replication stress and DNA damage responses, resulting in acute cell death. Suppression of the transcription and translation of G4-containing genes is also implicated in the anticancer effects of telomestatin. Because telomestatin is rare, labile, and insoluble, synthetic oxazole telomestatin derivatives have been developed and verified for their therapeutic efficacies in preclinical cancer models. Furthermore, a variety of G4-stabilizing compounds have been reported as promising seeds for molecular cancer therapeutics. To improve the design of future clinical studies, it will be important to identify predictive biomarkers of drug efficacy.

Research Progress of Targeting G-quadruplex Anticancer Agents

Progress in the Study of G-quadruplex-targeted Telomerase Inhibitors

Developing Novel G-Quadruplex Ligands: from Interaction with Nucleic Acids to Interfering with Nucleic Acid–Protein Interaction

Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics

G-quadruplexes: targets in anticancer drug design.

Research progress on anticancer therapeutics targeting telomere/telomerase

Specific Targeting of Telomeric Multimeric G-quadruplexes by a New Triaryl-Substituted Imidazole.

Recent Advances in the Development of Ligands Specifically Targeting Telomeric Multimeric G-quadruplexes.

Design of Selective G-quadruplex Ligands As Potential Anticancer Agents

Benzimidazole-based small molecules as anticancer agents targeting telomeric G-quadruplex and inhibiting telomerase enzyme

G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy

Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands

DNA G-Quadruplex in Human Telomeres and Oncogene Promoters: Structures, Functions, and Small Molecule Targeting

Structure of G-Quadruplex in the Oncogene c-myc Promoter and Small Ligands Targeting the G-Quadruplex

Targeting G-quadruplex nucleic acids with heterocyclic alkaloids and their derivatives.

Natural products and their derivatives as G-quadruplex binding ligands

Molecular modeling studies of interactions between quindoline derivatives and G-quadruplex

Targeting G-quadruplex Nucleic Acids with Heterocyclic Alkaloids and Their Derivatives

Biological Function of G-Quadruplex Nucleic Acids and Potential Application in Medicinal Chemistry.

Novel quinoxaline analogs as telomeric G-quadruplex ligands exert antitumor effects related to enhanced immunomodulation

Molecular Recognition of the Hybrid-Type G-Quadruplexes in Human Telomeres